Cargando…
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
INTRODUCTION: We present here a strategy to identify immunogenic neoantigen candidates from unique amino acid sequences at the junctions of fusion proteins which can serve as targets in the development of tumor vaccines for the treatment of breastcancer. METHOD: We mined the sequence reads of breast...
Autores principales: | Mistretta, Brandon, Rankothgedera, Sakuni, Castillo, Micah, Rao, Mitchell, Holloway, Kimberly, Bhardwaj, Anjana, El Noafal, Maha, Albarracin, Constance, El-Zein, Randa, Rezaei, Hengameh, Su, Xiaoping, Akbani, Rehan, Shao, Xiaoshan M., Czerniecki, Brian J., Karchin, Rachel, Bedrosian, Isabelle, Gunaratne, Preethi H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512078/ https://www.ncbi.nlm.nih.gov/pubmed/37744342 http://dx.doi.org/10.3389/fimmu.2023.1188831 |
Ejemplares similares
-
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
por: Bhardwaj, Anjana, et al.
Publicado: (2015) -
A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis
por: Rankothgedera, Sakuni, et al.
Publicado: (2021) -
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2021) -
The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2018) -
Erratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 2020, 12, 722
por: Ju, Zhenlin, et al.
Publicado: (2020)